Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04087798 · ClinicalTrials.gov registry record · NA

Controlling Hypertension Through Education and Coaching in Kidney Disease

A NA study, sponsored by University of Michigan.

Completed
Registry status
NA
Development phase
320
Enrollment target

NCT04087798: Completed NA study, sponsored by University of Michigan.

NCT04087798 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 320 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (77% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04087798, a NA study, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
NA
Development phase
320 participants
Enrollment target

Study Summary

Chronic kidney disease (CKD) is a serious and growing public health problem. The purpose of this study is to find out if an educational worksheet, called the Encounter Decision Intervention (EDI), combined with health coaching helps CKD patients improve their blood pressure and other health outcomes. The research team hypothesizes that the intervention group will have greater improvement in CKD outcomes than the control group.

Primary Outcome

Changes in systolic blood pressure between baseline and 12 months will be compared between the intervention group and control group.

Interventions

  • BEHAVIORAL Health coaching
  • BEHAVIORAL Control-EDI
  • BEHAVIORAL Intervention-EDI

Trial Details

FieldValue
Enrollment Target 320 participants
Start Date 2020-02-04
Est. Completion 2025-12-03
Phase NA
University of Michigan

1,327 total trials

What the finished NCT04087798 record still lists

NCT04087798 is an interventional study that assigns participants to a tested intervention. The registered 320 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (77% lower).

The record links to 0 conditions, and to 3 interventions - of which Health coaching is the first listed.

NCT04087798 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04087798 about?

NCT04087798 is a clinical study titled "Controlling Hypertension Through Education and Coaching in Kidney Disease". Chronic kidney disease (CKD) is a serious and growing public health problem. The purpose of this study is to find out if an educational worksheet, called the Encounter Decision Intervention (EDI), combined with health coaching helps CKD patients improve their blood pressure and other health outcomes...

What is the current status of trial NCT04087798?

This trial is currently completed. It is a NA study. The enrollment target is 320 participants. The study started on 2020-02-04. Estimated completion is 2025-12-03.

What interventions are being tested in trial NCT04087798?

The interventions under investigation include: Health coaching (BEHAVIORAL), Control-EDI (BEHAVIORAL), Intervention-EDI (BEHAVIORAL).

Who is sponsoring clinical trial NCT04087798?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04087798's enrollment target sits among peer trials

320 315th of 2000 higher than 1,680 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02763683 · 320 participants

    Investigations of Dementia in Parkinson Disease

  • NCT03331198 · 320 participants · Phase 1

    Study Evaluating Safety and Efficacy of JCAR017 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)

  • NCT03458832 · 320 participants

    Clinical Trial Readiness to Solve Barriers to Drug Development in FSHD

  • NCT03551951 · 320 participants

    Tumor Cell and DNA Detection in the Blood, Urine, and Bone Marrow

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04087798, the US trial registry maintained by the National Library of Medicine. NCT04087798 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.